AssetMark Inc’s MiMedx Group MDXG Stock Holding History

AssetMark Inc’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35	Closed	–	–	1741
2017 Q4	$0	Buy	+35	New	+$427	﹤0.01%	2019
2017 Q1	–	Sell	-17	Closed	–	–	1370
2016 Q4	$0	Buy	+17	New	+$153	﹤0.01%	1331

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AssetMark Inc's MDXG Position: Q1 2018 in Review

AssetMark Inc sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 35 shares.

AssetMark Inc first reported a position in MDXG in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

AssetMark Inc reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
AssetMark Inc sold 35 MiMedx Group shares in Q1 2018.
AssetMark Inc first reported a position in MiMedx Group in Q4 2016 and held it in 2 quarters.
AssetMark Inc's MiMedx Group position peaked at $0 in Q4 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.